Surgery Partners, Inc.SGRYNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank15
3Y CAGR-3.5%
5Y CAGR-8.0%
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

3Y CAGR
-3.5%/yr
vs -12.2%/yr prior
5Y CAGR
-8.0%/yr
Recent acceleration
Acceleration
+8.7pp
Accelerating
Percentile
P15
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
202510.17-16.5%
202412.17-21.1%
202315.43+36.3%
202211.32-33.0%
202116.89+9.3%
202015.46+34.4%
201911.50-39.8%
201819.09+84.7%
201710.34+15.8%
20168.92-